Sarepta Therapeutics Inc (SRPT)

Debt-to-capital ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Long-term debt	US$ in thousands	1,133,660	1,132,520	1,236,760	1,235,520	1,234,280	1,544,290	1,542,770	1,100,870	1,098,850	1,096,880	1,094,910	1,092,980	1,091,110	992,493	700,470	694,156	687,953	681,900	436,421	431,040
Total stockholders’ equity	US$ in thousands	961,192	859,337	764,357	741,411	712,749	384,950	430,840	726,457	856,886	928,009	469,528	485,108	535,445	761,759	892,047	1,042,870	1,144,830	818,187	995,204	1,099,170
Debt-to-capital ratio		0.54	0.57	0.62	0.62	0.63	0.80	0.78	0.60	0.56	0.54	0.70	0.69	0.67	0.57	0.44	0.40	0.38	0.45	0.30	0.28

March 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,133,660K ÷ ($1,133,660K + $961,192K)
= 0.54

The debt-to-capital ratio of Sarepta Therapeutics Inc has shown fluctuations over the past few quarters. In the most recent quarter ending March 31, 2024, the ratio stood at 0.54, indicating that 54% of the company's capital structure was funded by debt. This represents a slight decrease from the ratio of 0.57 at the end of December 31, 2023.

Overall, the trend in the debt-to-capital ratio has been somewhat volatile, with fluctuations observed between 0.28 and 0.80 over the past five years. The ratio peaked at 0.80 in December 31, 2022, and has since shown a declining trend, reaching its lowest point at 0.28 in September 30, 2019.

A higher debt-to-capital ratio indicates a higher level of financial risk as the company relies more heavily on debt to fund its operations. Conversely, a lower ratio suggests a more conservative financial structure with a higher proportion of equity financing.

It is important for stakeholders to closely monitor changes in the debt-to-capital ratio to assess the company's financial health, risk profile, and ability to service its debt obligations.